Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?
- 11 September 2020
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (1), 281-286
- https://doi.org/10.1245/s10434-020-09123-z
Abstract
Genetic predisposition accounts for 5–10% of all breast cancers (BC) diagnosed. NCCN guidelines help providers identify appropriate candidates for coThis publication has 25 references indexed in Scilit:
- Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics ProfessionalsAmerican Journal of Clinical Oncology, 2016
- Breast cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Pathology of hereditary breast cancerCellular Oncology, 2011
- Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencingProceedings of the National Academy of Sciences, 2010
- Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007Cancer, 2008
- Ten Genes for Inherited Breast CancerCancer Cell, 2007
- Referral and Experience with Genetic Testing Among Women with Early Onset Breast CancerGenetic Testing, 2005
- Polygenic susceptibility to breast cancer and implications for preventionNature Genetics, 2002
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996